Clinical Trial Update: Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event [NA]

View source ↗

Summary

ClinicalTrials.gov update describes a study on continuous temperature monitoring to detect cytokine release syndrome during immunotherapy, with the trial curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Release Syndrome
• Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Neoplasms
• Precursor B-lymphoblastic Leukemia Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cytokine Release Syndrome, Neoplasms | NA | Status: NOT_YET_RECRUITING